2014-06-16
Ark Biosciences Licenses Novel Drug Candidate from Roche for Potential Treatment of RSV infection
Ark Biosciences announced a licensing agreement for Roche's Respiratory Syncytial Virus (RSV) drug candidate AK0529...
know more >